Table of Contents

April 01, 2002; Volume 69, Issue 4 suppl 2

Proceedings of the 10th International Vasculitis and ANCA Workshop

• Pathogenesis

  • • Induction of Pauci-Immune Necrotizing and Crescen-Tic Glomerulonephritis (NCGN) by Intravenous Administration of Anti-Myeloperoxidase (Anti-MPO) Antibodies to Recombinase Activating Gene-2 Deficient (Rag-2 -/-) Mice

      JC Jennette, H Xiao, P Heeringa, Z Liu, P Hu, M Zhao, Y Aratani and RJ Falk

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-13;
    • Induction of Necrotizing and Crescentic Glomeru-Lonephritis (NCGN) and Small-Vessel Vasculitis (SVV) by Adoptive Transfer of Anti-Myeloperoxidase (Anti-MPO) Lymphocytes into Recombinase Activating Gene-2 Deficient (Rag-2 -/-) Mice

      H Xiao, P Heeringa, Z Liu, P Hu, M Zhao, Y Aratani, RJ Falk and JC Jennette

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-13;
    • Contribution of Activated Neutrophils and Mpo-Anca to the Development of Crescentic Glomeru-Lonephritis in Scg/Kj Mice

      A Ishida-Okawara, T Ito-Ihara, T Ono, E Muso, K Saiga, K Nemoto and K Suzuki

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-13-SII-14;
    • Known infectious causes of vasculitis in man

      Stanley J. Naides, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-15-SII-19;
    • HCV and cryoglobulinemic vasculitis

      C. Ferri, MD, A.L. Zignego, MD, D. Giuggioli, MD, M. Sebastiani, MD, M. Cazzato, MD, A. Antonelli, MD, L. La Civita, MD, P. Fadda, MD, G. Longombardo, BS and S. Pileri, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-20-SII-23;
    • Infections in primary vasculitides

      J.W. Cohen Tervaert, MD, PhD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-24-SII-26;
    • Staphylococcal Toxic-Shock-Syndrome-Toxin-1 (TSSt-1) is a Risk Factor for Disease Relapse in Wegener’s Granulomatosis

      ER Popa, B van der Meer, J Arends, WM Manson, NA Bos, CGM Kallenberg, JW Cohen Tervaert and CA Stegeman

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-27;
    • Chlamydia Pneumoniae and Giant-Cell Arteritis: Failure to Detect Chlamydia Pneumoniae in Temporal Artery Biopsies by Polymerase Chain Reaction in 90 Cases and 90 Controls

      MJ Regan, BJ Wood, Y-H Hsieh, ML Theodore, TC Quinn, DB Hellmann, WR Green, CA Gaydos and JH Stone

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-27;
    • Pathogenic mechanisms in giant cell arteritis

      Cornelia M. Weyand, MD and Jörg J. Goronzy, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-28-SII-32;
    • Implications for pathogenesis of patterns of injury in small- and medium-sized-vessel vasculitis

      J. Charles Jennette, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-33-SII-38;
    • Superantigenic Activation of T Lymphocytes and Endothelial Cells: A Mechanism for Superantigen-Induced Vasculitis

      PA Brogan, V Shah, N Klein and MJ Dillon

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-39;
    • Analysis of Autoantibody Repertoires in Small and Medium Sized Vessel Vasculitis: Evidence for Disease-Specific Perturbations in Classic Polyarteritis Nodosa (PAN), Micropolyangiitis (MPA), Churg-Strauss Syndrome (CSS) and Wegener’s Granulomatosis (WG)

      Y Chanseaud, L Guillevin, M Kambouchner, MC Boissier and L Mouthon

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-39;
    • Granuloma formation, implications for the pathogenesis of vasculitis

      Michael C. Sneller, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-40-SII-43;
    • Chemokine Receptor Expression on CD4+ and CD8+ Memory T-Cells and in Granulomas in Wegener’s Granulomatosis

      P Lamprecht, A Erdmann, A Mueller, E Csernok, H Bruehl, WL Gross and M Mack

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-44;
    • Genetic Resistance to Wegener’s Granulomatosis—A Role for CCR5 in Patients Without Antineutrophil Cytoplasmic Antibodies

      Y Zhou, D Huang, C Farver and G Hoffman

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-44;
    • Endothelial cell biology, perivascular inflammation, and vasculitis

      Maria C. Cid, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-45-SII-49;
    • Novel Effects of Inflammatory Cell Proteases on Vascular Endothelia

      GA Preston, WF Pendergraft, JJ Yang, JC Jennette and RJ Falk

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-50;
    • Understanding the pathogenesis of ANCA: Where are we today?

      Gloria A. Preston, PhD, Jia Jin Yang, MD, Hong Xiao, MD and Ronald J. Falk, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-51-SII-54;
    • TNF-α-Accelerated Apoptosis Abrogates Anca-Mediated Neutrophil Respiratory Burst by a Caspase-Dependent Mechanism

      R Kettritz, J Scheumann, Y Xu, FC Luft and H Haller

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-55;
    • Membrane Expression of Neutrophil Proteinase 3 (Pr3) Is Associated With Relapse in Pr3-Anca Related Vasculitis

      AA Rarok, CA Stegeman, PC Limburg and CGM Kallenberg

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-55;
    • ANCA subsets: Influence on disease phenotype

      Ulrich Specks, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-56-SII-59;
    • Sequential Epitope Mapping of the Myeloperoxidase Antigen

      DM Wynn and JA James

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-60;
    • Genetics of ANCA-associated vasculitides

      Cees G.M. Kallenberg, MD, PhD, Agnieszka Rarok, BSc and Coen A. Stegeman, MD, PhD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-61-SII-63;
    • Membrane Expression of Proteinase 3 is Genetically Controlled

      A Schreiber, A Busjahn, FC Luft and R Kettritz

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-64;
    • Genetic Polymorphisms in TNF, IL-1, IL-6 And Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Wegener’s Granulomatosis (WG)

      Y Zhou, D Huang and GS Hoffman

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-64;
    • Classification of anti–endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications

      Yehuda Shoenfeld, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-65-SII-66;
    • HMG-CoA Reductase Inhibitors Decrease Anca-Mediated Activation Of Human Neutrophils

      M Choi, S Rolle, M Rane, H Haller, FC Luft and R Kettritz

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-68;
    • Host and viral genes that control herpesvirus vasculitis

      Herbert W. Virgin IV, MD, PhD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-7-SII-12;

• Epidemiology of Vasculitis

  • • Kawasaki disease: Etiology, pathogenesis, and treatment

      Karyl S. Barron, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-69-SII-78;
    • Epidemiology of giant-cell arteritis

      Gene G. Hunder, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-79-SII-82;
    • Ethnic Disparity in the Incidence of Temporal Arteri-Tis: a 32-Year Experience at an Urban Medical Center

      MJ Regan, WR Green and JH Stone

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-83;
    • Epidemiology of Wegener’s granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome

      Richard A. Watts, DM, FRCP, David G.I. Scott, MD, FRCP and Suzanne E. Lane, MB, MRCP

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-84;
    • Epidemiology of Henoch-Schönlein purpura

      Frank T. Saulsbury, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-87;
    • Henoch-Schönlein Purpura and Cutaneous Leukocy-Toclastic Angiitis Exhibit Different HLA-DRB1 Associations

      MM Amoli, W Thomson, AH Hajeer, MC Calviño, C Garcia-Porrua, WER Ollier and MA Gonzalez-Gay

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-90;

• Diagnostic Modalities, Surrogate Markers of Disease Activity, and Tools for Outcome Measurements

  • • Cytokines in giant-cell arteritis

      Jörg J. Goronzy, MD, PhD and Cornelia M. Weyand, MD, PhD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-91-SII-94;
    • Utility of imaging studies in assessment of vascular inflammation

      Daniël Blockmans, MD, PhD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-95-SII-99;
    • Measuring disease activity and outcomes in clinical studies

      Raashid Luqmani, DM, FRCP (Edin)

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-100-SII-102;
    • Increases of PR3 and MPO Gene Transcription in Circulating Leukocyte of Anca-Associated Disease Correlate with Disease Activity

      JJ Yang, GA Preston, DA Alcorta, BD Phillips, RP Thomas, SL Hogan, JC Jennette and RJ Falk

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-103;
    • Cardiac Involvement in Wegener’s Granulomatosis: Echocardiographic Features and Clinical Outcomes

      GHM Oliveira, JB Seward and U Specks

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-103;
    • Endothelial Microparticles: Just Blood “Dust,” or a “Must” for the Diagnosis and Monitoring of Disease Activity in Childhood Vasculitides?

      PA Brogan, V Shah, C Brachet, N Klein and MJ Dillon

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-103-SII-104;
    • Diagnostic strategies in vasculitis affecting the central nervous system

      Leonard H. Calabrese, DO

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-105-SII-108;
    • Circulating Endothelial Cells and Vasculitis

      A Woywodt, F Streiber, K de Groot, H Haller and M Haubitz

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-109;
    • Diffuse Endothelial Dysfunction is a Common Feature of SNV

      PA Bacon, RJ Stevens, DM Carruthers, AD Diler, K Raza and J Townend

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-109;

• Treatment and Outcomes

  • • Conventional treatment and outcome of Wegener’s granulomatosis and microscopic polyangiitis

      David R.W. Jayne, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-110-SII-115;
    • Randomized Trial of Cyclophosphamide Versus Methotrexate for Induction of Remission in “Non-Renal” Anca-Associated Vasculitis

      K de Groot, N Rasmussen, JW Cohen Tervaert and DRW Jayne

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-116;
    • Treatment of giant-cell arteritis: where we have been and why we must move on

      Gary S. Hoffman, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII117-SII120;
    • Henoch-Schönlein purpura (treatment and outcome)

      Michael J. Dillon, FRCP, FRCPCH

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-121-SII-123;
    • Targeted therapies in systemic vasculitis

      John H. Stone, MD, MPH

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-124-SII-128;
    • Campath 1-H (Anti-CD52) for Refractory Vasculitis: Retrospective Cambridge Experience 1989–1999

      DRW Jayne

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-129;

• Treating the Permanent Sequelae of Vasculitis

  • • Inflammation in acute coronary syndromes

      Mark Robbins, MD and Eric J. Topol, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-130-SII-142;
    • Kidney transplantation and ANCA-associated vasculitis

      F. J. van der Woude, MD, PHD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-143-SII-145;
    • Surgical treatment of Takayasu’s disease

      Joseph M. Giordano, MD, FACS

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-146-SII-148;
    • New approaches to the management of subglottic stenosis in Wegener’s granulomatosis

      Isaac Eliachar, MD, James Chan, MD and Lee Akst, MD

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-149-SII-151;
    • Sinonasal complications of vasculitic diseases

      Robert S. Lebovics, MD, FACS

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-152-SII-154;

• Poster Presentations

  • • Pathogenesis—Immune Predisposition and Infectious Etiology of Systemic Vasculitis

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-155-SII-157;
    • Pathogenesis—Patterns of Injury: Implications for Pathogenesis

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-157-SII-159;
    • Pathogenesis—Possible Role of ANCA and AECA in Selected Forms of Systemic Vasculitis

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-160-SII-165;
    • Epidemiology of Vasculitis

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-165-SII-171;
    • Diagnostic Modalities, Surrogate Markers of Disease Activity, and Tools for Outcome Measurements

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-171-SII-179;
    • Treatment and Outcomes

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-179-SII-191;
    • Treating the Permanent Sequelae of Vasculitis

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-191-SII-192;

• Author Index

  • • Author Index

      • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-193-SII-196;

PreviousNext

Back to top

In this issue

Cleveland Clinic Journal of Medicine

Vol. 69, Issue 4 suppl 2

1 Apr 2002

Table of Contents Table of Contents (PDF) Index by author

Sign up for alerts

Jump to

• Pathogenesis
• Epidemiology of Vasculitis
• Diagnostic Modalities, Surrogate Markers of Disease Activity, and Tools for Outcome Measurements
• Treatment and Outcomes
• Treating the Permanent Sequelae of Vasculitis
• Poster Presentations
• Author Index

• Editor's Picks
• Most Cited
• Most Read

• Acute vertigo in a 67-year-old woman: Peripheral or central?
• How can I differentiate delirium from altered mental status in hospitalized older adults?
• Immunoglobulin E: From horses to myeloma
• New guidance on primary aldosteronism: Rethinking screening in hypertension
• Lemierre syndrome (septic thrombophlebitis of the internal jugular vein)

More...

More...